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Three dimensional 
echocardiography in valvular 
heart disease
Doppler. As might be expected, the major limitation of this ap-
proach is “stitching” artefacts that are created when the sub-
volumes are not aligned. This occurs in two situations - firstly when 
the heart rhythm is irregular, e.g. ectopic beats or atrial fibrillation 
and secondly when there is significant translational motion of the 
heart with, for example, respiration or other patient movements. 
Single heart beat large volume acquisitions are under development; 
however a limitation of current technology is that as the volume of 
interest increases in size, image quality is compromised in terms of 
spatial and temporal resolution. If a smaller 3-D volume is obtained, 
then live or real time 3-D imaging with good resolution and frame 
rates is possible. This is useful for studying a single structure of 
interest such as the mitral valve or atrial septum and removes the 
problem of irregular heart rhythms. However, currently there is no 
colour Doppler available with live 3-D imaging. As with all echo 
techniques, 3-D methods are still dependent on obtaining an 
adequate echo window. 
An image on a flat plane monitor is created by using two-dimen-
sional (2-D) “pixels”. In 3-D imaging, “voxels” or volume pixels are 
acquired and for the operator to appreciate all three dimensions 
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VALVE DISEASE 
AND 3-D Echo-
cArDIogrAphy
IntroductIon And technology overvIew 
This article aims to give an overview of the applications of 3-D 
echocardiography in the assessment and treatment of valvular 
disease in adults in current clinical practice. There has been 
considerable evolution in technology since the initial description of 
three-dimensional (3-D) echocardiography several decades ago.(1) 
The first generation of 3-D probes performed gated acquisition 
with static rendering of images, but not in real time. The second 
generation did to an extent allow real-time imaging but the rela-
tively low density of active elements (approximately 300) resulted 
in low sampling rate and compromise to image quality. Current 
3-D probes, due to the high element count (>3000), deliver the 
high sampling rates necessary to achieve clinically useful real-time 
3-D imaging with high image resolution and satisfactory frame 
rates. 
Imaging in 3-D essentially involves the acquisition of a volume data-
set over one or more heartbeats, depending on volume size. In 
“full-volume” acquisitions, typically four or more sub-volumes, are 
acquired with ECG gating and are stitched together to create a 
larger volume. This is used for larger structures, for example in 
assessment of left ventricular function and volumes. “Full-volume” 
acquisition can also be performed with colour Doppler to assess 
origin and shapes of flow jets in 3-D. This often requires more sub-
volumes and ECG-cycles (typically seven), and the total volume 
acquired is often smaller than the “full volume” without colour 
Although cardiac structures exist in three dimensions, two 
dimensional (2-d) echocardiography only provides informa-
tion in a single tomographic plane, the orientation of which 
is determined by the ultrasound window. Accordingly the 
use of geometric assumptions and/or mental integration of 
information from multiple 2-d images are needed to assess 
cardiac function and structure. Advances in ultrasound tech-
nology and image reconstruction have opened up the possi-
bility of using three dimensional (3-d) techniques in both 
quantitative applications such as measurement of ventri-
cular volumes and qualitative applications such as the 
assessment of valve stenosis or regurgitation. Further tech-
nical improvements in terms of real-time 3-d imaging and 
development of 3-d transoesophageal echo (toe) probes; 
have opened up further applications including intra-opera-
tive guidance of percutaneous valve interventions. 
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on a 2-D display, the perception of “depth” is achieved by shading 
techniques. The volumetric datasets can be “cropped” in either 
standard tomographic planes or oblique planes to remove un-
wanted structures and display the regions of interest. Measure-
ments can be made of distance or area from any 2-D plane within 
the 3-D dataset, but direct measurements from the 3-D image 
display are currently not possible although an appreciation of size 
can be made by overlaying a grid of known dimensions.
clInIcAl ApplIcAtIons oF 3-d                              
Imaging in 3-D provides clear appreciation of the true shape of 
cardiac structures and the spatial relationships between them. Full 
evaluation of valvular heart disease, whether for diagnosis or 
planning of an intervention, requires accurate delineation of the 
actual valve pathology but also assessment of any consequent 
cardiac dysfunction including assessment of ventricular size and 
function (see below). 3-D methods can also be used for assessment 
of ventricular dyssynchrony and for morphological assessment in 
congenital lesions, but these applications will not be discussed 
further in this review. Table 1 shows common clinical applications of 
3-D-transthoracic and transoesophageal echo. The clinical utility of 
3-D echocardiography in valvular disease is well illustrated by its use 
in mitral valve disease, which will be covered in more detail. Once 
the reader has grasped these concepts they will be able to apply 
the principles to other valve lesions. 
the leFt And rIght ventrIcles                            
Assessment of left ventricular systolic function by 2-D echo has 
several potential sources of error, including geometric assumptions 
that do not account for wall motion abnormalities or irregular 
ventricular shapes, and acquisition of foreshortened images, both 
of which can result in significant inter-observer and inter-study 
variability. 3-D echo avoids these problems and current equipment 
allows LV-image acquisition over a few heartbeats and semi-
automated post processing within a few minutes. Using cardiac 
magnetic resonance imaging (MRI) as gold standard, several studies 
have compared 2-D and 3-D echo methods of assessing LV volumes 
and mass. 2-D methods appear to underestimate LV volumes but 
overestimate LV mass, whereas 3-D echo shows good agreement 
with MRI.(2-4) Recently the additional assessment of left ventricular 
volumes by 3-D echo in unselected patients in a multi-centre 
setting was shown to be quick (five extra minutes on average), 
and altered the management of significant numbers of patients 
compared to estimation of systolic function by 2-D echo alone.(5) 
The accuracy of 3-D echo and ability to detect small but significant 
changes in systolic volumes is likely to contribute to decisions 
regarding optimum timing of valve surgery. This may be parti- 
cularly advantageous in difficult clinical situations such as the 
asymptomatic patient with apparent severe valvular disease.
The right ventricle presents difficulties in assessment of systolic 
function due to its unique shape. Comparison of 3-D echo with 
MRI has shown good agreement for RV volumes, but not mass.(6,7) 
Right ventricular volumes have been measured by 3-D echo in a 
200 patient series with a variety of conditions by Tamborini et al., 
who reported that this appears feasible with a mean of 3 minutes 
for image acquisition and 4 minutes for analysis. They also reported 
good correlation of 3-D ejection fraction with conventional indices 
of RV function such as tricuspid annulus plane systolic excursion 
(TAPSE).(8)
 
tAble 1: clinical applications of 3-D
RT = real-time. FV = full volume. ASD = atrial septal defects. PFO = patent foramen ovale.
Advantages of 3-d echo
Qualitative 
Accurate depiction of anatomy
Demonstration of spatial relationships between cardiac structures
Quantitative
Accurate and reproducible chamber volumes and mass (TTE FV)
Regional timings and dys-synchrony (TTE FV)
Accurate mitral valve area planimetry (TTE FV & RT TOE)
Precise multi-dimensional measurements of defects such as PFO/ASD (RT TOE)
Indications of 3-d echo
Established indications 
Accurate left ventricular volumes and ejection fraction 
Assessment of mitral regurgitation/stenosis
Intra-operative guidance of transcatheter interventional procedures
Assessment of prosthetic valve function/dysfunction
Assessment of congenital heart disease 
Emerging indications
Assessment of aortic stenosis/regurgitation
Accurate right ventricular volumes and ejection fraction 
Intra-operative guidance of mitral valve surgery
Assessment for cardiac resynchronisation
Useful in theory but no clear indication yet
Assessment of tricuspid/pulmonary valve disease
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the mItrAl vAlve                                                       
The mitral valve with its complex geometry comprising the annulus, 
leaflets and sub-valve apparatus is ideally suited to 3-D assessment. 
The mitral annulus is saddle shaped, with high points at the anterior 
and posterior regions and low points at the leaflet commissures. 
The posterior leaflet inserts into two-thirds of the mitral annular 
circumference, while the anterior leaflet is larger by area and 
approximately accounts for two-thirds of the total valve area. 
The posterior leaflet is divided into 3 regions P1 (anterolateral), 
P2 (middle) and P3 (posteromedial), and the anterior leaflet is 
divided into opposing segments A1-A3. 
mItrAl regurgItAtIon                                              
Mitral regurgitation can arise from several mechanisms – classified 
by Carpentier. Type I - leaflet motion is normal, but regurgitation 
arises from reduced coaptation (e.g. mitral annular dilatation); 
Type II – leaflet motion is excessive (e.g. myxomatous or flail 
leaflets); and Type III – leaflet motion is restricted (e.g. ischaemic 
papillary muscle dysfunction). Guidelines emphasise the benefits 
of valve preservation by repair on patient outcomes.(9) An accurate 
description of the mechanism of valve failure is required to predict 
the techniques needed and likelihood of achieving successful mitral 
repair. This helps to guide the decision on the best time to intervene 
and offer surgery, as increasingly mitral repair is being performed in 
asymptomatic patients with severe mitral regurgitation.(10,11) How-
ever, if there is a high chance that the valve may be replaced then 
surgery is better delayed until symptoms develop or other para-
meters are met such as a dilating ventricle or falling left ventri- 
cular ejection fraction. Assessment of the mitral valve by 2-D echo 
requires the operator to obtain multiple views through all segments 
of the two leaflets. This requires considerable expertise and 
experience, but even then errors in interpretation may occur. 
By comparison 3-D echo (TTE or TOE), can give a rapid overview 
of the mitral valve using the en-face or “surgical view” of the 
mitral valve from the left atrium. The extent of any prolapsing or 
restricted leaflet segments, the commissures, leaflet coaptation 
line and mitral annulus can be seen and images can also be rotated 
to view the valve from the ventricular side. Figure 1 shows several 
examples of posterior mitral leaflet prolapse on 3-D echo and 
illustrates how this allows appreciation of differences between 
them. 3-D echo also gives the ability to perform accurate segment 
by segment analysis. Rapid online analysis can be performed by 
viewing the dataset in multiplanar reconstruction format to define 
short axis and long axis views of the mitral valve. Using established 
landmarks the entire coaptation line can be assessed from the 
anterolateral commissure, P1 and A1 segments through P2, A2 and 
then P3, A3 and the posteromedial commissure. The relationship 
of each segment to the annulus can be accurately assessed. 
Measurements can be made of segment prolapse or tenting in 
relation to the annulus. Suggested protocols for obtaining the sur-
gical view and segmental analysis are summarised in Table 2, while 
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FIgure 1: Surgical view of the mitral valve on transoesophageal 
echocardiography, showing 4 examples of p2 segment prolapse. 
Image 1: prolapse of the lateral portion of p2 and part of p1, with 
chordal rupture in that region. Image 2: central portion of p2 is 
flail with chordal rupture. The regurgitant jet tracks over A2 
where a deep ridge is visible. Image 3: A lateral portion of p2 
prolapse with chordal rupture. There is a deep “cleft” in the p2 
segment, extending back to the annulus, on the right of the prolapse. 
Image 4: central p2 segment prolapse with several points of 
chordal rupture.
 
tAble 2: Suggested protocols for obtaining the surgical view and 
segmental analysis
Surgical view 
TTE parasternal long axis-live 3-D data set               
 or parasternal short axis-live 3-D data set 
TOE mid oesophageal long axis-live 3-D data set /zoom mode 
   - rotate image to look on to mitral valve from left atrium
   - optimise image to see leaflets in entirety    
Segmental analysis
TTE parasternal long axis-full volume 3-D data set 
 or apical long axis-full volume 3-D data set 
TOE mid oesophageal long axis-live 3-D data set /zoom mode  
   - biplane imaging  
   - optimise image to see left atrium/leaflets/annulus/subvalve
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Figure 2 gives an example of segmental analysis. Dedicated mitral 
valve quantification software (e.g. MVQ, Phillips Medical) is available 
for use with 3-D TOE datasets – an example is given in Figure 3. 
This can give a very detailed assessment with accurate measure-
ments of the annulus and leaflets, papillary muscle position and 
aortic-mitral angles, and is likely to play an important role in pre-
operative planning of mitral valve repair in the future.
The literature confirms the clinical utility of 3-D echo in mitral re-
gurgitation and the comparison of real time 3-D TTE with 2-D TOE 
has shown comparable high sensitivity, specificity and accuracy for 
identifying prolapsing mitral segments.(12) However in that study a 
small proportion (11%) of patients were excluded due to insuffi-
cient image quality by transthoracic echo. Macnab et al. compared 
2-D and 3-D TOE assessment of the mitral valve against the gold 
standard of surgical findings, and reported that 3-D TOE is more 
accurate at identifying the location and extent of leaflet prolapse – 
particularly at the most medial and lateral portions of the valve.(13) 
More recently, Grewal et al. performed a similar study and also 
found superior performance of 3-D TOE, particularly in identifying 
complex disease involving multiple segments or both leaflets.(14) 
Assessment of the severity of mitral regurgitation by 2-D echo can 
be challenging, particularly with eccentric jets. 3-D colour Doppler 
allows better visualisation of the origin, size and shape of jets.(15,16) 
The vena contracta and proximal isovelocity surface area (PISA) 
methods are other common methods used to quantify severity of 
mitral regurgitation, the latter also allowing calculation of effective 
regurgitant orifice area and regurgitant volume.(17) The conven-
tional PISA method assumes a hemispheric shape of the isovelo- 
city surface, which very often is not the case. 3-D methods allow 
assessment of the true shape of proximal flow convergence region 
and also permit more accurate measurement of the PISA and vena 
contracta.(18,19) 
In clinical practice 3-D used as part of the initial TTE study could 
largely replace the need for initial 2-D TOE as this allows more 
confident assessment of leaflet morphology, and hence the likeli-
hood of successful repair and timing of intervention. Once the 
decision for surgery is made a TOE with 3-D imaging could be 
FIgure 2: Segmental analysis of the mitral valve: Transthoracic 
full-volume 3-D dataset taken from the parasternal long axis 
window. Using multiplanar reconstruction format long axis and 
short axis views are displayed at three levels. The level of each 
segment is confirmed in short axis and then assessed during systole 
in long axis. The images shows p2 flail segment with additional 
prolapse of p3 and A3.
FIgure 3: Severe mitral regurgitation was seen through a deep 
cleft in p2. Detailed analysis with MVQ software, showed a severely 
dilated annulus with total loss of its normal saddle shape and no 
significant prolapse - confirming that the primary lesions were the 
deep cleft in p2 and the annular dilatation. 
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performed to accurately define valve anatomy and dimensions used 
for pre-operative planning. 
While surgical repair remains the therapy of choice in severely 
regurgitant mitral valves, functional mitral regurgitation often 
involves significant left ventricular impairment. Such patients may 
face significant risk from conventional surgery and percutaneous 
approaches are currently being explored. MitraClip (Evalve Inc) is 
one example, based on the surgical Alfieri operation, and inserted 
using a transvenous approach and atrial septal puncture. The 
“clip” is positioned over the regurgitant orifice grasping both mitral 
leaflet free edges, creating a double orifice with significant reduc-
tion in mitral regurgition.(20) 3-D TOE imaging provides excellent 
assessment of the mitral annulus dimensions, location and extent 
of the regurgitant orifice and leaflet morphology; all essential in 
planning the procedure. During the procedure 3-D echo is also of 
considerable value.(21) The position of trans-septal puncture is cru-
cial - if it is too high or too low on the atrial septum the delivery 
system may either not reach the valve or assume an awkward angle 
making clip deployment impossible. 3-D imaging allows a precise 
atrial-septal puncture, and accurate positioning over the mitral valve 
leaflets during clip deployment. Once successfully deployed, assess-
ment of residual regurgitant jets and how this relates to valve 
anatomy can also be performed using 3-D.
mItrAl stenosIs                                                           
The commonest cause for mitral stenosis is rheumatic heart 
disease. Stenosis severity is quantified in terms of mean trans- 
mitral gradient and mitral orifice area.(22) Methods that calculate 
the “effective” mitral orifice area include pressure half time 
measurement (PHT), continuity equation and PISA (proximal 
isovelocity surface area) methods. However these have their 
limitations - the Doppler derived mitral valve area is influenced by 
factors including tachycardia, heart rhythm, non-linear Doppler 
velocity curves, concomitant valvular disease, and is not applicable 
in the immediate period post balloon valvuloplasty. 
Direct planimetry can be used to measure the true “anatomic” 
orifice area. This is considered to be the reference method in 
clinical practice having been shown to correlate more precisely to 
direct measurement of anatomic orifice at surgery than other 
Doppler methods.(23) However the mitral valve is often funnel- 
shaped and the stenotic orifice may be situated obliquely within 
the ventricle. 2-D planimetry is limited by difficulties in obtaining 
the minimum cross sectional area during planimetry measure-
ments. This method demands considerable experience and ex-
pertise to define the correct orientation of the true mitral valve 
orifice. 3-D TTE helps locate the plane with the smallest mitral 
valve orifice as the image can be viewed using multi-planar 
reformatting to align with the orifice in long and short axis, 
(Figure 4). Use of 3-D has been shown to be an accurate method 
for assessing mitral valve area, faster and more reproducible than 
2-D echo.(24,25) If the patient is in atrial fibrillation, rather than 
“full-volume”, live 3-D imaging should be used. Invasive catheter 
measurements using Gorlin’s method has also been compared to 
3-D echo and the latter appears to correlate more closely to other 
non-invasive methods.(26) Another limitation of 2-D echo plani-
|metry is the presence of significant calcification particularly when 
within the leaflets. This can be overcome by 3-D TOE imaging, 
as clear imaging of the orifice is possible from the left atrial en- 
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FIgure 4: 3-D ToE live “zoom” mode of a stenotic mitral valve: 
Multiplanar reconstruction method to accurately locate and 
quantify true anatomic mitral valve orifice area by planimetry.
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face view as calcific shadowing is cast into the left ventricle. 
Alternatively the use of 3-D TTE with colour Doppler is another 
solution.(27) It seems likely that 3-D techniques will become the 
new “gold standard” for quantifying mitral valve area.
Percutaneous balloon valvuloplasty is an effective treatment for 
appropriately selected patients with rheumatic mitral stenosis. 
3-D TOE can provide accurate information on the functional 
significance and morphology of the valve to determine suitability 
for balloon valvuloplasty. Accurate peri-procedural evaluation of 
the mechanism and effect of valvuloplasty is also desirable - with 
3-D assessment one can determine the increase in valve area 
and whether this has occurred due to commissural splitting as 
intended, or due to leaflet tearing. It is also recognised that 
Doppler-derived measures of mitral valve area are inaccurate 
immediately post valvuloplasty due to acute changes in left atrial 
compliance and transmitral gradient.(28) The most reliable method 
of assessing change in area is direct planimetry and 3-D TTE has 
been shown to correlate best immediately post procedure with 
invasive measurements.(29)
prosthetIc vAlve Assessment                               
When considering prosthetic valve function traditional methods 
focus on assessment of flow characteristics. 2-D Doppler para-
meters are used to describe the effective orifice area. However, 
not uncommonly we encounter the problem of “high velocities” 
across the valve. The differential diagnosis includes a normal 
finding for that particular valve type and size, patient prosthesis 
mismatch or valve malfunction e.g. due to pannus formation. 
Assessment of prosthetic valve morphology by 2-D echo is limited 
by artefact and shadows cast around the prosthesis, particularly 
with mechanical valves. 
3-D TOE, and to a lesser extent 3-D TTE, can clearly demonstrate 
prosthetic valve morphology and disc/leaflet motion can be 
observed in real time.(30,31) 3-D echo also provides clear images 
of mitral repair and dehiscence of annuloplasty rings can be 
appreciated, (Figure 5). Para-valvular leaks can be identified by a 
combination of 3-D zoom and 3-D FV colour imaging, (Figure 6). 
Real time 3-D TOE has been shown to be superior in assessing 
the site and extent of para-valvular leaks as compared with 
2-D TOE.(32)
AortIc vAlve                                                               
In aortic stenosis, indices of severity include the peak jet velocity 
and mean transaortic gradient as well as effective orifice area (by 
the Doppler derived continuity equation).(22) However, conti- 
nuity equation assessment of valve area makes assumptions over 
the LVOT tract shape, which can be more accurately measured 
with 3-D echocardiography. Hybrid measurements using 2-D 
Doppler derived aortic valve velocity time integral and 3-D 
derived LV stroke volume have shown promise in this regard.(33) 
Direct assessment of aortic valve area by 2-D echo is challenging 
since unequal restriction of leaflets can lead to the aortic valve 
opening becoming distorted and this is further compounded by 
the presence of calcification. Although the principles of 3-D valve 
FIgure 5: Left image shows a mitral valve repaired with an 
annuloplasty band. right images show partial band dehiscence 
(white arrows) from the annulus with a visible unravelled suture. 
FIgure 6: Left image St Jude’s bi-leaflet mechanical valve with 
pannus formation over leaflets and two large regions of valve 
dehiscence (white arrows). right image depicts paravalvular 
regurgitation identified with 3-D colour Doppler.
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planimetry can be applied to aortic stenosis,(34) the role of such 
measurements are limited and are not recommended except 
where Doppler methods are unavailable.(22) In one TOE study the 
aortic valve, was optimally visualised in only 18% of subjects as 
compared to >90% for the mitral valve.(35) However, the majority 
were normal aortic valves with thin pliable leaflets. Acoustic 
shadowing can limit the 3-D anatomic assessment of aortic 
stenosis.
Although one study has shown that the severity of aortic 
regurgitation can be accurately quantified by measuring the vena 
contracta area using 3-D echo (rather than width as in 2-D), and 
conceptually such an approach appears attractive, further studies 
are needed and currently this has not yet entered routine clinical 
use.(36) The additional morphological information gained from 3-D 
imaging of the aortic valve may also be useful where there is a 
discrepancy between clinical and echocardiographic data. A good 
example is in the presence of subaortic membranes, which can be 
easily missed by 2-D techniques.(37)
Transcatheter Aortic Valve Implantation (TAVI) is a novel mini- 
mally invasive treatment for aortic stenosis. 3-D TOE allows addi-
tional information about the left ventricular outflow tract and 
aortic annulus size before the procedure, as well as confirming the 
presence of a tri-leaflet aortic valve (a bicuspid valve is a relative 
contra-indication to TAVI due to increased risk of displacement of 
the prosthesis). 3-D TOE during the procedure can guide positioning 
of the valve to ensure that it will sit clear of nearby structures 
including the basal interventricular septum, anterior mitral valve 
leaflet and coronary arteries; the 3-D spatial orientation of these 
structures are not readily appreciated by fluoroscopy or 2-D 
imaging alone. 3-D TOE can also be invaluable in detecting compli-
cations immediately after deployment including the location and 
extent of paravalvular regurgitation. 
rIght-sIded vAlve dIseAse                                      
It seems intuitive that the 3-D techniques described above in rela-
tion to the mitral and aortic valves would also be well suited to 
assessment of the right sided heart valves. However currently 
there are only a few reports in the literature so far regarding the 
use of 3-D techniques in assessment of tricuspid valve disease.(38,39)
FInAl comments                                                           
Traditional 2-D imaging emphasises acquiring specific on-axis views 
to produce standardised images, as chamber measurements made 
in these views are prognostic markers in many disease states. 
3-D imaging requires a different approach to scanning. Since 3-D 
imaging offers enface views of cardiac structures it requires a 
clear understanding of cardiac anatomy. Appreciation of the ori-
entation of the heart in 3-D within the chest and how cardiac 
structures are related to one other are essential to fully utilise the 
potential of 3-D echocardiography. As with all new techniques 
there is a significant learning curve and image quality is still 
dependent on echocardiographic windows. Once users become 
familiar with the technology, adding 3-D acquisitions onto a 
standard 2-D study typically requires only a few extra minutes, 
although further time may be required afterwards for “post-
processing”. 3-D echocardiography provides incremental informa-
tion over standard 2-D techniques, allowing more accurate 
assessment of cardiac and in particular valvular disease. This can 
be used to refine the diagnosis and better guide the treatment of 
patients. Some of the common clinical applications of the techno-
logy have been described above, although the clinical uses of 3-D 
echocardiography will likely continue to grow.
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